Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
Clinical trial NCT02145403 · COMPLETED
Trial details
- NCT number
- NCT02145403
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-11-26
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.